Page last updated: 2024-10-21

2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Parkinson Disease, Secondary

2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with Parkinson Disease, Secondary in 1 studies

2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine: mutagen from fried ground beef; structure given in first source
PhIP : An imidazopyridine that is 1H--imidazo[4,5-b]pyridine which is substituted at positions 1, 2, and 6 by methyl, amino, and phenyl groups, respectively. It is the most abundant of the mutagenic heterocyclic amines found in cooked meat and fish.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agim, ZS1
Cannon, JR1

Other Studies

1 other study available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Parkinson Disease, Secondary

ArticleYear
Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.
    Toxicology letters, 2018, May-01, Volume: 287

    Topics: Animals; Corpus Striatum; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Imidazol

2018